Literature DB >> 26453281

Evolution of insulin patents and market exclusivities in the USA.

Jing Luo1, Aaron S Kesselheim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26453281     DOI： 10.1016/S2213-8587(15)00364-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  10 in total

1.  Tertiary patenting on drug-device combination products in the United States.

Authors:  Reed F Beall; Aaron S Kesselheim
Journal:  Nat Biotechnol       Date:  2018-02-06       Impact factor: 54.908

2.  Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Authors:  Xilin Zhou; Sundar S Shrestha; Hui Shao; Ping Zhang
Journal:  Diabetes Care       Date:  2020-07-31       Impact factor: 19.112

Review 3.  Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.

Authors:  Jing Luo; Walid F Gellad
Journal:  Curr Diab Rep       Date:  2020-01-29       Impact factor: 5.430

4.  Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?

Authors:  Reed F Beall; Jason W Nickerson; Warren A Kaplan; Amir Attaran
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

5.  Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.

Authors:  Chenxi Liu; Xinping Zhang; Chaojie Liu; Margaret Ewen; Zinan Zhang; Guoqin Liu
Journal:  BMC Health Serv Res       Date:  2017-08-24       Impact factor: 2.655

6.  Production costs and potential prices for biosimilars of human insulin and insulin analogues.

Authors:  Dzintars Gotham; Melissa J Barber; Andrew Hill
Journal:  BMJ Glob Health       Date:  2018-09-25

Review 7.  A global perspective on the issue of access to insulin.

Authors:  David Beran; Maria Lazo-Porras; Camille M Mba; Jean Claude Mbanya
Journal:  Diabetologia       Date:  2021-01-23       Impact factor: 10.122

8.  Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015.

Authors:  Peggah Khorrami; Michael S Sinha; Aditi Bhanja; Heidi L Allen; Aaron S Kesselheim; Benjamin D Sommers
Journal:  JAMA Netw Open       Date:  2022-01-04

9.  Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability.

Authors:  Amna Saeed; Krizzia Lambojon; Hamid Saeed; Zikria Saleem; Naveed Anwer; Muhammad Majid Aziz; Wenjing Ji; Wenchen Liu; Chen Chen; Caijun Yang; Yu Fang; Zaheer-Ud-Din Babar
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

10.  The global intellectual property ecosystem for insulin and its public health implications: an observational study.

Authors:  Warren A Kaplan; Reed F Beall
Journal:  J Pharm Policy Pract       Date:  2016-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.